Astec Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21

Sales

167.92

253.64

384.01

445.34

231.23

Operating profit

-65.98

-0.28

58.73

108.33

45.76

Interest

16.38

12.47

8.45

5.89

3.20

Gross profit

-79.48

-10.10

56.97

111.19

44.26

EPS (Rs)

-39.93

-11.04

15.14

34.59

11.25

Other income

2.89

2.65

6.69

8.76

1.70

Stock adjustment

61.72

-14.51

-28.04

-9.74

-48.26

Raw material

100.10

193.15

273.32

266.84

177.98

Power and fuel

-

-

-

-

-

Employee expenses

31.16

32.63

28.01

29.58

20.74

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

40.92

42.66

52.00

50.34

35.02

Provisions made

-

-

-

-

-

Depreciation

20.77

18.57

17.13

19.73

14.69

Taxation

-21.93

-7.02

10.16

23.69

7.54

Net profit / loss

-78.31

-21.65

29.69

67.78

22.04

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

19.61

19.61

19.60

19.60

19.59

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-39.29

-0.11

15.29

24.32

19.79

GPM (%)

-46.53

-3.94

14.58

24.49

19.00

NPM (%)

-45.85

-8.45

7.60

14.93

9.46